Literature DB >> 25772046

Commentary on "pANCA positivity predicts lower clinical response to infliximab therapy among patients with IBD".

Edmund Leung1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25772046     DOI: 10.14423/SMJ.0000000000000252

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


× No keyword cloud information.
  1 in total

1.  Serum PR3-ANCA Is a Predictor of Primary Nonresponse to Anti-TNF-α Agents in Patients with Ulcerative Colitis.

Authors:  Atsushi Yoshida; Katsuyoshi Matsuoka; Fumiaki Ueno; Toshio Morizane; Yutaka Endo; Toshifumi Hibi
Journal:  Inflamm Intest Dis       Date:  2021-04-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.